ARCHIVES

Cancer Groups Endorse Pazdur For FDA Commissioner.

This article is from The Cancer Letter archive.

Vol. 27 No. 03 | January 19, 2001

Download PDF Visit The Full Archive

Related Articles

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

NIH Grant Funding to Use Percentiles Instead Of Priority Scores; Minimal Impact Seen By NCI

January 22, 1988

Public Health Service: NIEHS, CDC to Study Population Exposure to Environmental Estrogens

December 12, 1997

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

UICC Announces Four Grant award Programs

July 14, 1978

No Controversy Over Cancer Act This Time

May 25, 1990